메뉴 건너뛰기




Volumn 45, Issue 5, 2005, Pages 547-554

Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules

Author keywords

Extended release hydromorphone HCl; Pharmacokinetics

Indexed keywords

HYDROMORPHONE; NALOXONE; NALTREXONE;

EID: 17644392128     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270005274552     Document Type: Article
Times cited : (14)

References (9)
  • 1
    • 0001886508 scopus 로고    scopus 로고
    • Opioid analgesics and antagonists
    • Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. New York: McGraw-Hill
    • Riesine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996:535.
    • (1996) Goodman & Gilman's the Pharmacological Basis of Therapeutics , pp. 535
    • Riesine, T.1    Pasternak, G.2
  • 2
    • 0035088248 scopus 로고    scopus 로고
    • Hydromorphone: Pharmacology and clinical applications in cancer patients
    • Sarhill N, Walsh D, Nelson KA. Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer. 2001;9:84-96.
    • (2001) Support Care Cancer , vol.9 , pp. 84-96
    • Sarhill, N.1    Walsh, D.2    Nelson, K.A.3
  • 3
    • 17644414461 scopus 로고    scopus 로고
    • Two double blind randomized trials of once-a-day controlled release oral hydromorphone (Palladone XL) compared to immediate release hydromorphone dosed QID
    • October 1999; Ft. Lauderdale, Fla. Abstract 645
    • Weinstein S, Lacouture PG, Grosser AB, et al. Two double blind randomized trials of once-a-day controlled release oral hydromorphone (Palladone XL) compared to immediate release hydromorphone dosed QID. Presented at: American Pain Society 18th annual meeting, October 1999; Ft. Lauderdale, Fla. Abstract 645.
    • American Pain Society 18th Annual Meeting
    • Weinstein, S.1    Lacouture, P.G.2    Grosser, A.B.3
  • 4
    • 0003484310 scopus 로고    scopus 로고
    • Bethesda, Md: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research
    • Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. Bethesda, Md: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2001.
    • (2001) Guidance for Industry: Bioanalytical Method Validation
  • 6
    • 0035699860 scopus 로고    scopus 로고
    • Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid® IR) in young and elderly subjects
    • Durnin C, Hind ID, Ghani SP, Yates DB, Cross M. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid® IR) in young and elderly subjects. Proc West Pharmacol Soc. 2001;44:79-80.
    • (2001) Proc West Pharmacol Soc , vol.44 , pp. 79-80
    • Durnin, C.1    Hind, I.D.2    Ghani, S.P.3    Yates, D.B.4    Cross, M.5
  • 7
    • 0035699648 scopus 로고    scopus 로고
    • Effect of food on the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR)
    • Durin C, Hind ID, Channon E, Yates DB, Cross M. Effect of food on the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR). Proc West Pharmacol Soc. 2001;44:75-76.
    • (2001) Proc West Pharmacol Soc , vol.44 , pp. 75-76
    • Durin, C.1    Hind, I.D.2    Channon, E.3    Yates, D.B.4    Cross, M.5
  • 8
    • 0035697768 scopus 로고    scopus 로고
    • Dose proportionality of the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR)
    • Durin C, Hind ID, Ghani SP, Yates DB, Cross M. Dose proportionality of the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR). Proc West Pharmacol Soc. 2001;44:73-74.
    • (2001) Proc West Pharmacol Soc , vol.44 , pp. 73-74
    • Durin, C.1    Hind, I.D.2    Ghani, S.P.3    Yates, D.B.4    Cross, M.5
  • 9
    • 0036792244 scopus 로고    scopus 로고
    • Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers
    • Drover DR, Angst MS, Valle M, et al. Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. Anesthesiology. 2002;97:827-836.
    • (2002) Anesthesiology , vol.97 , pp. 827-836
    • Drover, D.R.1    Angst, M.S.2    Valle, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.